Dyskinesia: Research and Treatment: Psychopharmacology Series, cartea 2
Editat de D. E. Casey, T. N. Chase, A. V. Christensen, J. Gerlachen Limba Engleză Paperback – 23 noi 2011
Preț: 702.80 lei
Preț vechi: 739.79 lei
-5% Nou
Puncte Express: 1054
Preț estimativ în valută:
134.54€ • 139.85$ • 111.55£
134.54€ • 139.85$ • 111.55£
Carte tipărită la comandă
Livrare economică 08-22 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642701429
ISBN-10: 3642701426
Pagini: 244
Ilustrații: X, 230 p.
Dimensiuni: 170 x 244 x 13 mm
Greutate: 0.4 kg
Ediția:Softcover reprint of the original 1st ed. 1985
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Psychopharmacology Series
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642701426
Pagini: 244
Ilustrații: X, 230 p.
Dimensiuni: 170 x 244 x 13 mm
Greutate: 0.4 kg
Ediția:Softcover reprint of the original 1st ed. 1985
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Psychopharmacology Series
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Preclinical Aspects.- Brain Dopamine Receptors in Schizophrenia and Tardive Dyskinesia.- Receptor-Binding Profiles of Neuroleptics.- Functional Classification of Different Dopamine Receptors.- Pharmacological Properties of Presynaptic Dopamine Receptor Agonists.- Influence of GABA Mimetics and Lithium on Biochemical Manifestations of Striatal Dopamine Target Cell Hypersensitivity.- New Aspects on the Role of Dopamine, Acetylcholine, and GABA in the Development of Tardive Dyskinesia.- Discussion Section.- Differential Effects of Dopamine D-1 and D-2 Agonists and Antagonists in 6-Hydroxydopamine-Lesioned Rats.- Clinical Aspects.- Is Tardive Dyskinesia a Unique Disorder?.- Tardive Dyskinesia: Prevalence, Incidence, and Risk Factors.- Involuntary Disorders of Movement in Chronic Schizophrenia — The Role of the Illness and Its Treatment.- Tardive Dyskinesia: Reversible and Irreversible.- Pathophysiological Mechanisms Underlying Tardive Dyskinesia.- Chemical and Structural Changes in the Brain in Patients with Movement Disorder.- Medical Treatment of Dystonia.- The Effect of Dopamine Antagonists in Spontaneous and Tardive Dyskinesia.- GABA Dysfunction in the Pathophysiology of Tardive Dyskinesia.- Clinical Activity of GABA Agonists in Neuroleptic- and L-Dopa-Induced Dyskinesia.- Tardive Dyskinesia: Nondopaminergic Treatment Approaches.- Pathophysiology of L-Dopa-Induced Abnormal Involuntary Movements.- Discussion Section.- Prevalence of Tardive Dyskinesia in a Clinic Population.- Animal Models.- Differential Alteration of Striatal D-1 and D-2 Receptors Induced by the Long-Term Administration of Haloperidol, Sulpiride or Clozapine to Rats.- Pharmacological Differentiation of Dopamine D-1 and D-2 Antagonists After Single and Repeated Administration.- Pathophysiology ofTardive Dyskinesia.- Intermittent Treatment with Droperidol, a Short-Acting Neuroleptic, Increases Behavioral Dopamine Receptor Sensitivity.- Induction and Reversal of Dopamine Dyskinesia in Rat, Cat, and Monkey.- Behavioral Effects of Long-Term Neuroleptic Treatment in Cebus Monkeys.- Induction of Tardive Dyskinesia in Cebus apella and Macaca speciosa Monkeys: A Review.- List of Contributors.